Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder.
- DOI
- 10.1177/28314425261505125
- Published
- 2026 Nov 4
- Container
- Psychedelic medicine (New Rochelle, N.Y.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/28314425261505125,
title = {Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder.},
author = {Bystritsky A and Bishay AAED and Spivak NM and Paulsen R and Treanor M and Fanselow MS and Craske MG},
year = {2026},
journal = {Psychedelic medicine (New Rochelle, N.Y.)},
doi = {10.1177/28314425261505125},
url = {https://doi.org/10.1177/28314425261505125}
}RIS
TY - JOUR TI - Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder. AU - Bystritsky A AU - Bishay AAED AU - Spivak NM AU - Paulsen R AU - Treanor M AU - Fanselow MS AU - Craske MG PY - 2026 JO - Psychedelic medicine (New Rochelle, N.Y.) DO - 10.1177/28314425261505125 UR - https://doi.org/10.1177/28314425261505125 ER -
APA
A, B., AAED, B., NM, S., R, P., M, T., MS, F., & MG, C. (2026). Letter: Reconsidering Scopolamine as a Psychedelic Adjunct in Exposure-Based Therapy: Cholinergic Modulation and Fear Extinction in Social Anxiety Disorder.. Psychedelic medicine (New Rochelle, N.Y.). https://doi.org/10.1177/28314425261505125
Source records
- pubmed · retrieved 2026-11-10T13:34:51.280Z